Molecular Structure of Clorazepate dipotassium (CAS NO. 57109-90-7):

EINECS: 260-565-6
IUPAC Name: Dipotassium 7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylate hydroxide  
Molecular Formula: C₁₆H₁₁ClK₂N₂O₄
Molecular Weight: 408.91914 g/mol
H-Bond Donor: 2
H-Bond Acceptor: 5
Canonical SMILES: C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)[O-].[OH-].[K+].[K+]
InChI: 1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2
InChIKey: QCHSEDTUUKDTIG-UHFFFAOYSA-L
Flash Point: 294.8 °C
Enthalpy of Vaporization: 89.15 kJ/mol
Boiling Point: 563.9 °C at 760 mmHg
Vapour Pressure: 1.5E-13 mmHg at 25 °C
Storage Temp.: 2-8 °C

Safety Information of Clorazepate dipotassium (CAS NO. 57109-90-7):
Hazard Codes: Xn ,T ,F 
Risk Statements: 22-63-39-23/24/25-11
R22:Harmful if swallowed
R63:Possible risk of harm to the unborn child
R39:Danger of very serious irreversible effects
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed
R11:Highly flammable
Safety Statements: 22-36/37/39-45-36/37-16
S22:Do not breathe dust
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37:Wear suitable protective clothing and gloves
S16:Keep away from sources of ignition
RIDADR: 3249
WGK Germany: 3
RTECS: DE8750000
HazardClass: 6.1(b)
PackingGroup: III
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. Experimental reproductive effects. Mutation data reported. A tranquilizer. When heated to decomposition it emits very toxic fumes of Cl⁻, NO_x and K₂O.

  Clorazepate dipotassium with cas registry number of 57109-90-7 is also known as Clorazepate Dipotassium [USAN:JAN] ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1) ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compd. with potassium hydroxide (1:1) ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compound with potassium hydroxide (1:1) ; 4306 CB ; AB 35616 ; AH 3232 ; Abbott-35616 ; Belseren ; Bipotassium chlorazepate ; CB 4306 ; Clorazepate ; Chlorazepam ; Chlorazepate ; Clorazepate acid dipotassium salt ; Clorazepate dipotassique ; Clorazepate dipotassique [INN-French] ; Clorazepate dipotassium ; Clorazepato ; Clorazepato [DCIT] ; Clorazepato dipotasico ; Clorazepato dipotasico [INN-Spanish] ; DEA No. 2768 ; Dikalii clorazepas ; Dikalii clorazepas [INN-Latin] ; Dipotassium chlorazepate ; Dipotassium clorazepate ; Gen-Xene ; Mendon ; Modiur ; Nevracten ; Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate KOH ; Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate compound with potassium hydroxide (1:1) ; Softramal ; TR 19119 ; Tencilan ; Tranex ; Transilium ; Tranxene ; Tranxene SD ; Tranxilen ; Tranxilene ; Tranxilium ; UNII-63FN7G03XY .